Pharmaceuticals Direct Limited

Pharmaceuticals Direct Ltd is a large, holding company with an active status, having operated for 25 years. Based in Loughton, Kent, the company employs 24 people and holds assets worth £32,689,545, generating a yearly revenue of £33,644,545. It functions as a regular importer and exporter of pharmaceutical products, with 35 months of import activity and 163 months of export activity recorded. The company operates an e-commerce site and is managed by three directors and one owner, with Pharmadent Holdings Imited owning the company.

The company’s core business revolves around pharmaceutical distribution, storage, procurement, and healthcare. It offers services including 3PL warehousing, product sourcing, and efficient delivery, catering to wholesalers, pharmacies, hospitals, and research institutions. It even has a dedicated division for dental supplies through DHB Oral Healthcare, offering a range of products from trusted brands.

Financially, Pharmaceuticals Direct Ltd shows some concerning trends. While turnover increased by 8.3% to £34 million, net assets only increased by 1.7% to £36 million. Cash reserves fell by 3.1% to £210,000, and bank borrowings dropped significantly by 100% to zero. Creditors decreased by 31%, suggesting improved debt management. A notable decline in administrative expenses by 1.4% to £3.6 million may indicate cost-cutting measures. However, the surge in amounts owed by group undertakings by 1.8% to £20 million warrants further investigation. The company’s size (meeting two of three criteria for a large company) and its established presence in the industry suggest a degree of stability, but the fluctuating financial indicators require close monitoring. No auditor is mentioned, likely due to the company’s exemption as a large company.

Registered in England/Wales under the registration number 03884028, with a registered address at IG10 4PL, Old Station Road, Loughton.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.